Genomate Health

Genomate Health is a digital health company. The company's algorithm predicts the efficacy of each drug for a specific patient by calculating the cumulative score of each match between the drug and the genomic profile, thereby ranking therapies targeting cancer driver gene alterations. Genomate offers this model as a Class I medical device certified with the EU CE mark. Oncology clinics in Central and Eastern Europe have integrated this algorithm into their workflows to support molecular tumor boards in recommending targeted therapies for specific patients.